These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunology and the changing profile of leprosy. Job CK Lepr India; 1978 Apr; 50(2):214-30. PubMed ID: 353384 [No Abstract] [Full Text] [Related]
4. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
5. Transfer factor as a probe of the immune defect in lepromatous leprosy. Hastings RC Int J Lepr Other Mycobact Dis; 1977; 45(3):281-91. PubMed ID: 336558 [No Abstract] [Full Text] [Related]
6. The immunology of leprosy; unravelling an enigma. Choudhuri K Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):430-47. PubMed ID: 7594927 [No Abstract] [Full Text] [Related]
7. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients. Robinson P; Mahadevan PR J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228 [TBL] [Abstract][Full Text] [Related]
8. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Nath I; Van Rood JJ; Mehra NK; Vaidya MC Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335 [TBL] [Abstract][Full Text] [Related]
9. Towards a vaccine against leprosy. Sengupta U Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444 [No Abstract] [Full Text] [Related]
10. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Convit J; Pinardi ME; RodrÃguez Ochoa G; Ulrich M; Avila JL; Goihman M Clin Exp Immunol; 1974 Jun; 17(2):261-5. PubMed ID: 4619359 [TBL] [Abstract][Full Text] [Related]
11. Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy. Godal T; Rees RJ Int J Lepr Other Mycobact Dis; 1970; 38(4):439-42. PubMed ID: 4929374 [No Abstract] [Full Text] [Related]
12. [Recent development in immunology of leprosy: roles of immunoregulatory cytokines in the establishment of immuno-unresponsiveness to M. leprae in leprosy patients]. Tomioka H Nihon Rai Gakkai Zasshi; 1995 Jul; 64(2):69-84. PubMed ID: 7592164 [No Abstract] [Full Text] [Related]
13. Vaccines in leprosy. Desikan KV Indian J Lepr; 1987; 59(2):127-32. PubMed ID: 3309082 [No Abstract] [Full Text] [Related]
14. The cellular and molecular basis of immunity against mycobacterial diseases. Colston MJ Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118 [No Abstract] [Full Text] [Related]
17. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research. Sengupta U; Sinha S Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337 [No Abstract] [Full Text] [Related]
18. Recent advances in the immunology of leprosy. Convit J; Ulrich M Int J Dermatol; 1976 Apr; 15(3):157-70. PubMed ID: 770348 [No Abstract] [Full Text] [Related]
19. The lepromatous macrophage defect as related to vaccine development in leprosy. Skinsnes OK Int J Lepr Other Mycobact Dis; 1976; 44(4):485-90. PubMed ID: 798730 [No Abstract] [Full Text] [Related]
20. Does the suppression of the immune response in pre-clinical lepromatous leprosy affect both cell-mediated and humoral responses in Mycobacterium leprae antigens? Stoner GL Lepr Rev; 1981 Mar; 52(1):102-3. PubMed ID: 7017316 [No Abstract] [Full Text] [Related] [Next] [New Search]